Sonidegib in Locally Advanced Basal Cell Carcinoma: A Monocentric Retrospective Experience and a Review of Published Real-Life Data

SIMPLE SUMMARY: Basal cell carcinoma (BCC) is one of the most common malignancies worldwide. Some patients may develop locally advanced BCC with significant morbidity and with reduction in life quality. The employment of a Hedgehog inhibitor known as Vismodegib has already proven itself helpful in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazzaro, Gianluca, Benzecry, Valentina, Mattioli, Maria A., Denaro, Nerina, Beltramini, Giada A., Marzano, Angelo V., Passoni, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377077/
https://www.ncbi.nlm.nih.gov/pubmed/37509282
http://dx.doi.org/10.3390/cancers15143621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377077/
https://www.ncbi.nlm.nih.gov/pubmed/37509282
http://dx.doi.org/10.3390/cancers15143621

Ejemplares similares